( e Journal in the March issue. ...)Female sex hormones play a vital role in defense against sexually transmitted diseases
Navigation Links
Female sex hormones play a vital role in defense against sexually transmitted diseases
e Journal in the March issue.
'"/>
Source:McMaster University
Related biology news :
1. Female volunteers prepare for a second bedrest
2. Female butterflies go for sparkle -- not size -- when choosing to mate
3. Female guppies risk their lives to avoid too much male attention
4. Female birds boost up their eggs when hearing sexy song
5. Female pronghorns choose mate based on substance as well as show
6. Update on census of worlds most endangered cat -- Female Amur leopard found dead
7. Female Antarctic seals give cold shoulder to local males
8. Female chimps keep the bullies at bay
9. Female-led infanticide in wild chimpanzees
10. Alcohol consumption disrupts breastfeeding hormones
11. Hyena mothers give their cubs a helpful dose of hormones
Post Your Comments:
Breaking Biology News(10 mins):AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Delivering medicine directly into a tumor 2List of 'unsung' wildlife affected by climate change released 2President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 1President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 2Panel assesses evidence for the collection and use of family health history information 55523 1Panel assesses evidence for the collection and use of family health history information 55523 2Panel assesses evidence for the collection and use of family health history information 55523 3Small rodents encourage the formation of scrubland in Spain 9717 1Small rodents encourage the formation of scrubland in Spain 9717 2
Other Biology News:IronKey Opens New European Office 2Emotion and scent create lasting memories -- even in a sleeping brain 2Novel publishing approach puts textbook in more hands 2Novel publishing approach puts textbook in more hands 3Novel publishing approach puts textbook in more hands 4
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3
[0] AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology[0] ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis[0] AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia[0] Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures
Other Biology Technology:Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement 2Catalyst Pharmaceutical Partners, Inc. Files Form S-3 Shelf Registration Statement 3BioStorage Technologies Forms Scientific Advisory Board with Leading Life Science Experts 2American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |